Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study ; volume:24 ; number:1 ; day:26 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
Trials ; 24, Heft 1 (26.3.2023), 1-14, 12.2023
- Urheber
-
Kal Omar, Ruba
Hagström, Anna
Stålhammar, Gustav
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-023-07245-9
- URN
-
urn:nbn:de:101:1-2023081310465776565606
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kal Omar, Ruba
- Hagström, Anna
- Stålhammar, Gustav
- SpringerLink (Online service)
Ähnliche Objekte (12)
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
Novel treatment paradigms for metastatic uveal melanoma
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Melatonin as an adjuvant therapy in preterm infants with neonatal sepsis, randomized trial
Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?
Melatonin: an anti-tumor agent for osteosarcoma
Melatonin: a potential intervention for hepatic steatosis
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
Carbon‐Nanotube Microelectrodes for Electrochemical Determination of Melatonin
Metformin as adjuvant therapy for glioma
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
Novel treatment paradigms for metastatic uveal melanoma
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Melatonin as an adjuvant therapy in preterm infants with neonatal sepsis, randomized trial
Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?
Melatonin: an anti-tumor agent for osteosarcoma
Melatonin: a potential intervention for hepatic steatosis
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
Carbon‐Nanotube Microelectrodes for Electrochemical Determination of Melatonin
Metformin as adjuvant therapy for glioma
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
Novel treatment paradigms for metastatic uveal melanoma
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Melatonin as an adjuvant therapy in preterm infants with neonatal sepsis, randomized trial
Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?
Melatonin: an anti-tumor agent for osteosarcoma
Melatonin: a potential intervention for hepatic steatosis
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
Carbon‐Nanotube Microelectrodes for Electrochemical Determination of Melatonin